Shares of Leap Therapeutics, Inc. nosedived more than 70% to an all-time low on Tuesday, making them the top loser across U.S. exchanges. The sharp drop — Leap’s worst intraday fall ever — came after ...

Leap Therapeutics has come crashing down to earth. The biotech axed plans to advance into phase 3 in gastric cancer on the basis of midstage data, sending its stock down 60% to below $1, but it is ...

Hiba Nawan shares exclusively with BT, about how she will no longer be a part of the show after the 20-year leap. Hiba Nawab; with Krushal Ahuja in the show ...